APELLIS PHARMACEUTICALS INC (APLS) Stock Cash Flow
NASDAQ:APLS - Nasdaq - US03753U1060 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -250.10M | -528.63M | -652.17M | -746.35M | -344.87M | |||
| Depreciation Amortization | 1.82M | 1.78M | 1.55M | 1.38M | 640.00K | |||
| Change In Working Capital | -89.27M | -200.17M | -15.70M | -93.52M | 19.59M | |||
| Interest Paid | 19.44M | 3.29M | 5.00M | 10.27M | 12.93M | |||
| Taxes Paid | 20.00K | 0.00 | 4.92M | N/A | N/A | |||
| Other non cash items | 132.44M | 132.28M | 152.57M | 275.37M | 164.16M | |||
| OPERATING CASH FLOW | -205.10M | -594.74M | -513.75M | -563.13M | -160.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -476.00K | -773.00K | -1.52M | -1.10M | -5.42M | |||
| Other Investing Activity | N/A | 99.00K | 61.42M | 248.72M | -311.57M | |||
| INVESTING CASH FLOW | -377.00K | -674.00K | 59.89M | 247.62M | -316.99M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -55.50M | 0.00 | 0.00 | 322.87M | |||
| Stock Issued/Repurchased | 44.28M | 461.04M | 405.84M | 398.02M | 392.42M | |||
| Other Financing Activity | 123.22M | -11.04M | -40.18M | -5.79M | -23.11M | |||
| FINANCING CASH FLOW | 149.33M | 394.50M | 365.66M | 392.24M | 692.18M | |||
| Exchange Rate Effect | 891.00K | 135.00K | -490.00K | -2.02M | 360.00K | |||
| CHANGE IN CASH | -55.26M | -200.77M | -88.69M | 74.71M | 215.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -205.10M | -594.74M | -513.75M | -563.13M | -160.49M | |||
| Capital Expenditure | -476.00K | -773.00K | -1.52M | -1.10M | -5.42M | |||
| FREE CASH FLOW | -205.58M | -595.51M | -515.27M | -564.23M | -165.91M | |||
All data in USD